Evaluation of the national cervical cancer screening program in Morocco: achievements and challenges

Objectives To report the key outcomes of evaluation of the national cervical cancer screening program in Morocco, and describe its organization, status of implementation, performance, and major challenges. Methods An evaluation team conducted program manager interviews and screening provider focus group discussions, supervisory visits to primary health and diagnostic centers, and review of published documents. Aggregated performance data collected by the Ministry of Health from the screening and diagnostic centers were analyzed. Results Screening is conducted using visual inspection with acetic acid. The program is opportunistic, with no mechanism to identify and invite eligible women. Coverage of the target population was very low (6.6% in 2015 and 7.7% in 2016). Positivity rates were 5.3% and 8.9% in 2015 and 2016 respectively, and varied widely between regions. Detection rate of cervical intraepithelial neoplasia (CIN) 2 or worse in 2016 was very low (0.9/1,000), with more invasive cancers detected than CIN 2/3. Lack of histopathology and treatment facilities at the Cancer Early Detection Centers is a major short-coming, and there is a need for service-provider refresher training. Without a computerized health information system tracking screen positive women, ensuring high treatment compliance and performing regular quality assurance are challenging. Conclusions The screening program in Morocco requires better organization, a pragmatic system of inviting the target population, improved compliance to diagnosis, treatment, and follow-up, improved provider training, better quality assurance systems, and an effective health information system with appropriate linkages for monitoring and evaluation.

[1]  C. Wild,et al.  Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar. , 2018, The Lancet. Oncology.

[2]  P. Basu,et al.  Secondary prevention of cervical cancer. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[3]  R. Hariprasad,et al.  Management algorithms for cervical cancer screening and precancer treatment for resource‐limited settings , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  P. Naud,et al.  Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  B. Lyoussi,et al.  Using surveillance data to understand cancer trends: an overview in Morocco , 2015, Archives of Public Health.

[6]  R. Sankaranarayanan,et al.  Meta‐analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review , 2014, BJOG : an international journal of obstetrics and gynaecology.

[7]  R. Sankaranarayanan,et al.  Accuracy of visual inspection with acetic acid for cervical cancer screening , 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8]  A. Herbert,et al.  European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.